(As of 31 Dec, 2021)
IISL Nifty Pharma TR INR
Investors understand that their principal will be at Very High Risk.
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
0.25 %(If redeemed within 90 days)
This fund is been allocated in various sectors including some of the prominent ones that are widely accepted and are creating a value of trust.
Sun Pharmaceuticals Industries Ltd
Divi's Laboratories Ltd
Dr Reddy's Laboratories Ltd
As the name suggests, Sectoral Funds invest in specific sectors of the economy. These funds are less diversified as they invest entirely in a particular sector; hence, their risk factor also depends on the respective sector’s performance, this carrying high risk. For example, a FMCG fund will only invest in FMCG companies while a tech fund will invest in only tech companies.The aim of these funds is to give investors a chance to benefit from the growth prospects of a particular fund.
This fund is rated 0 stars by Morning Star Ratings.